Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysisReview Published on 2022-11-012023-07-10 Journal: International journal of colorectal disease [Category] COVID19(2023년), [키워드] adverse outcome IBD IBD drug Meta-analysis SARS-CoV-2 [DOI] 10.1007/s00384-022-04265-w PMC 바로가기 [Article Type] Review
COVID-19 and Gut InjuryArticle Published on 2022-10-202022-11-15 Journal: Nutrients [Category] COVID19(2023년), SARS, 진단, [키워드] ACE2 acute respiratory syndrome angiotensin-converting enzyme 2 bind change children coronavirus COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients death develop disorder females GI Tract Gut high risk host cell IBD increased risk Inflammatory Inflammatory bowel disease inflammatory cell inhibitor Injury mechanism microbiota monoclonal antibody pandemic Pathologies Patient Probiotics receptor recruitment reduce Respiratory system SARS-CoV-2 secreted cytokine severe COVID-19 susceptible Symptom the disease the patient therapeutic option Viral load [DOI] 10.3390/nu14204409 PMC 바로가기
Aseptic Abscess Syndrome in Rheumatoid Arthritis PatientArticle Published on 2022-09-272022-11-15 Journal: Medicina [Category] 진단, [키워드] abdominal pain abscess accompanied adalimumab Antibiotics Aseptic aseptic abscess syndrome Autoimmune diseases Bacteria characterized Clinical improvement Complete corticosteroid therapy COVID-19 infection disorder extension feature Fever IBD include Inflammatory Inflammatory bowel disease Inflammatory marker internal organ joints lack lesion lesions Leukocytosis liver Lungs microbe neutrophilic parasites Patient potentially life-threatening Practitioner Prednisone recognize reduction Remdesivir Rheumatoid rheumatoid arthritis sensitivity spleen Symptom syndrome systemic symptom tissue treated Treatment viruses weight loss [DOI] 10.3390/medicina58101354 PMC 바로가기
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel DiseaseArticle Published on 2022-09-102022-11-16 Journal: Canadian journal of gastroenterology & hepatology [Category] SARS, 변종, [키워드] 95% CI AOR Characteristics Complete concern COVID-19 COVID-19 vaccination COVID-19 vaccine demographic dose drive effective healthcare worker hospital IBD identify individual Infection Inflammatory bowel disease information Misconception more unwell National pandemic Patient patients Pregnancy public health measure Responder risk the SARS-CoV-2 unique vaccination Vaccine Vaccine hesitancy variable virus variant was used with COVID-19 [DOI] 10.1155/2022/4527844 PMC 바로가기
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease PatientsArticle Published on 2022-09-082022-11-15 Journal: Journal of Crohn's & colitis [Category] SARS, 진단, 치료기술, [키워드] analysed anti-nucleocapsid antibody anti-SARS-CoV-2 vaccine anti-spike antibody antibody baseline bowel cellular Cohort cohorts Concentration controls COVID-19 decrease functional humoral IBD individual Inflammatory Inflammatory bowel disease inhibitor Necrosis no difference nucleocapsid antigen Patient patients positive recipient released repeated response SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibody SARS-CoV-2-specific T-cell response Seven simple T-lymphocyte the healthy Treatment vaccinated individual vaccination Vaccine vaccine dose vaccinee viral spike protein was performed were measured [DOI] 10.1093/ecco-jcc/jjac048 PMC 바로가기
Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON]Article Published on 2022-09-082022-11-15 Journal: Journal of Crohn's & colitis [Category] SARS, 진단, [키워드] Affect Against antagonists anti-SP IgG Anti-spike anti-TNF anti-tumour necrosis factor antagonists. Antibody Response booster vaccination bowel Cohort Complete COVID-19 COVID-19 vaccination determine Diagnosis diminished healthy control highlight IBD Immunoglobulin Impaired Inflammatory bowel disease inhibitor investigated medication mRNA vaccine Necrosis Patient Protein Quantitative receiving recruited response response to vaccination Result SARS-CoV-2 vaccination seroconvert seroconverted serological response significantly lower therapy TNF TNF antagonist Treatment vaccination vaccination against COVID-19 Vaccine vaccine response were assessed [DOI] 10.1093/ecco-jcc/jjac029 PMC 바로가기
Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD PatientsArticle Published on 2022-08-242022-11-15 Journal: Canadian journal of gastroenterology & hepatology [Category] SARS, 진단, [키워드] addition age analysed association Cohort collected Course COVID-19 COVID-19 infection death died Evidence First wave Frame General population Germany hospital hotspot IBD ICU Immunoglobulin immunomodulator Immunotherapy Impact increased risk infection risk Inflammatory bowel disease inhibitor majority medication Munich occurred Older age Other Oxygen treatment Patient patients patients died positive Prevent problem protective role question receive reduced respiratory respiratory tract respiratory tract infection Respiratory tract infections SARS-CoV-2 SARS-COV-2 infection season severe COVID-19 significantly subject Support susceptible symptomatic tested the healthy therapy TNF tract Treatment Winter [DOI] 10.1155/2022/3469789 PMC 바로가기
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study염증성 장질환이나 면역억제제는 심각한 COVID-19의 위험 증가와 관련이 없습니다: 관찰 네덜란드 코호트 연구Observational Study Published on 2022-08-012022-09-11 Journal: Clinical and experimental medicine [Category] SARS, 임상, 치료기술, [키워드] 95% confidence interval Admission affected Biological bowel Characteristics children clinical Cohort cohort characteristics cohort study Comorbidity COVID-19 COVID-19 case COVID-19 cases Crohn's disease Deceased determinant died disease examined Follow-up General population had no healthcare healthcare providers Hospital admission Hospitalized IBD ICD-10 Immunosuppressant immunosuppressants Immunotherapy increased risk Inflammatory bowel disease intensive care medication Mortality National observational study occurred Older outbreak Patient patients regions Respiratory Support Result retrospective risk factor Risk factors SARS-CoV-2 Seven severe COVID-19 significantly more the SARS-CoV-2 Thiopurine. Treatment was performed women [DOI] 10.1007/s10238-021-00755-3 PMC 바로가기 [Article Type] Observational Study
Hepatitis E infection with a benign course during vedolizumab treatment for Crohn’s disease: A case reportCase Reports Published on 2022-08-012023-06-11 Journal: Clinics and research in hepatology and gastroenter [Category] E형 간염, [키워드] Crohn's disease hepatitis E IBD vedolizumab [DOI] 10.1016/j.clinre.2022.101948 [Article Type] Case Reports
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases급성 후 COVID-19는 염증성 장 질환에서 장 바이러스 항원 지속성을 특징으로 합니다Article Published on 2022-08-012022-09-11 Journal: Gastroenterology [Category] COVID19(2023년), SARS, 임상, 치료기술, 치료법, [키워드] acute COVID-19 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 affected Antigen biochemical CD8 Chain Reaction clinical trials Confirmed COVID-19 infection controlled clinical trials coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection Culture detectable endoscopy enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated expression of SARS-CoV-2 flow cytometry globe Gut gut mucosa IBD immune immune response immunofluorescence immunosuppressive immunosuppressive therapy Inflammation Inflammatory bowel disease intestine investigated large intestine majority means Mild nucleocapsid nucleocapsid protein pandemic Patient performed persistence polymerase chain polymerase chain reaction populations Postacute COVID-19 Quantitative quantitative polymerase chain reaction questionnaire reported RNA SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus severity Stool syndrome T cells therapy tissue Viral antigen Viral Antigen Persistence. viral nucleocapsid protein viral transcripts virus cultivation [DOI] 10.1053/j.gastro.2022.04.037 PMC 바로가기 [Article Type] Article